You are searching for: hsa04390

---

T35173 Target Info	Target Name	Cellular inhibitor of apoptosis 2 (BIRC3)
	Target type	Clinical trial Target
	Disease	Squamous head and neck cell carcinom; Solid tumour/cancer;
	Drugs	AT-406	Drug Info

T12355 Target Info	Target Name	G1/S-specific cyclin-D1 (CCND1)
	Target type	Clinical trial Target
	Disease	Myelofibrosis; Relapsed or refractory chronic lymphocytic leukaemia;
	Drugs	ABT-263	Drug Info

T18639 Target Info	Target Name	Heparin-binding growth factor 1 (FGF1)
	Target type	Clinical trial Target
	Disease	Peripheral arterial disease; Coronary artery disease;
	Drugs	CVBT-141H	Drug Info

T04507 Target Info	Target Name	Presynaptic density protein 95 (DLG4)
	Target type	Clinical trial Target
	Disease	Cerebrovascular ischaemia; Stroke;
	Drugs	Tat-NR2B9c	Drug Info

T40491 Target Info	Target Name	Serine/threonine PP2A-alpha (PPP2CA)
	Target type	Clinical trial Target
	Disease	Molluscum contagiosum infection; Astrocytoma;
	Drugs	VP-102	Drug Info

T49989 Target Info	Target Name	TGF-beta receptor type II (TGFBR2)
	Target type	Clinical trial Target
	Disease	Solid tumour/cancer;
	Drugs	TGF-BR2 mab	Drug Info

T10828 Target Info	Target Name	Alpha-fetoprotein (AFP)
	Target type	Clinical trial Target
	Disease	Autoimmune diabetes; Liver cancer;
	Drugs	MM-093	Drug Info

T68383 Target Info	Target Name	Bone morphogenetic protein 2 (BMP2)
	Target type	Clinical trial Target
	Disease	Bone development disorder;
	Drugs	DWP-431	Drug Info

T39797 Target Info	Target Name	Frizzled-7 receptor (FZD7)
	Target type	Clinical trial Target
	Disease	Solid tumour/cancer;
	Drugs	OMP-18R5	Drug Info

T94695 Target Info	Target Name	Mothers against decapentaplegic homolog 7 (SMAD7)
	Target type	Clinical trial Target
	Disease	Crohn disease; Ulcerative colitis;
	Drugs	GED-0301	Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.